InMode (INMD) Change in Accured Expenses (2018 - 2025)
InMode (INMD) posted quarterly Change in Accured Expenses of $4.8 million for Q4 2025, up 212.16% year-on-year from $1.5 million in Q4 2024, and up 743.79% on a QoQ basis from $564000.0 in Q3 2025.
InMode (INMD) Change in Accured Expenses (2018 - 2025) Analysis & Trends
InMode (INMD) has reported Change in Accured Expenses for 8 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.
- Quarterly Change in Accured Expenses rose 212.16% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 12.83% YoY) and the FY2025 annual result came in at $2.2 million, up 12.83% from the prior year.
- Change in Accured Expenses advanced to $4.8 million in Q4 2025 per INMD's latest filing, from $564000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for INMD reached as high as $14.6 million in Q4 2022 and fell as low as -$23.0 million in Q1 2023.
- A 5-year average of $1.2 million and a median of $1.4 million in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 808.9% — and 2024, when it plunged 2179.9%.
- Year by year, Change in Accured Expenses stood at -$2.1 million in 2021, then surged by 808.9% to $14.6 million in 2022, then plunged by 98.6% to $204000.0 in 2023, then tumbled by 2179.9% to -$4.2 million in 2024, then soared by 212.16% to $4.8 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $4.8 million, $564000.0, and $127000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.76 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Sep 30, 2025 | 564,000.00 |
| Sep 30, 2025 | 564,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | -3.29 Mn |
| Mar 31, 2025 | -3.29 Mn |
| Dec 31, 2024 | -4.24 Mn |
| Dec 31, 2024 | -4.24 Mn |
| Sep 30, 2024 | 11.72 Mn |
| Sep 30, 2024 | 11.72 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | -7.80 Mn |
| Mar 31, 2024 | -7.80 Mn |
| Dec 31, 2023 | 204,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.04 Mn |